Status:
COMPLETED
Treatment for Psychogenic Disorders
Lead Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Movement Disorders
Eligibility:
All Genders
18+ years
Brief Summary
This study will examine whether biofeedback treatment is effective in lessening or stopping movement symptoms in people with psychogenic movement disorder. People with this condition have increased or...
Detailed Description
Objective: To apply respiratory biofeedback to patients with Psychogenic Movement Disorders (PMD) with a goal of decreasing involuntary movements. Study Population: Patients diagnosed with "clinica...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Clinically definite functional (psychogenic) movement disorder as defined by Fahn and Williams criteria diagnosed by a movement disorder neurologist.
- Patients who are at least 18 years old
- Able and willing to cooperate with the study requirements
- EXCLUSION CRITERIA:
- Any underlying major medical or neurological conditions
- Patients whose movements are related to a known neurological disorder
- History of traumatic brain injury or history of strokes
- Current suicidal ideation
- Patients with a psychotic disorder
- Patients with active substance abuse within the last 6 months
- Patients with moderate to severe depression, Beck Depression Inventory (BDI) greater than 18)
- Patients with any ongoing litigation related to their diagnosis of PMD.
- Patients with a definite overt stressor identified that is thought to be primarily responsible for the PMD symptoms
Exclusion
Key Trial Info
Start Date :
April 7 2006
Trial Type :
OBSERVATIONAL
End Date :
April 14 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00314444
Start Date
April 7 2006
End Date
April 14 2009
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892